(S)-(+)-Dimethindene maleate: Practical Guidance for M2 Muscarinic Antagonist Workflows

What This Product Solves

(S)-(+)-Dimethindene maleate provides a highly selective tool for antagonizing the M2 muscarinic acetylcholine receptor with minimal activity at M1, M3, and M4 subtypes. This selectivity is critical for researchers dissecting the muscarinic acetylcholine receptor signaling pathway in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. By also antagonizing histamine H1 receptors, it can help isolate cholinergic from histaminergic contributions in complex tissue or organ models.

The compound is supplied as a solid, with a clearly defined chemical structure (C20H24N2·C4H4O4), molecular weight of 408.5, and a purity of 98.00%. Its high aqueous solubility (≥20.45 mg/mL) makes it suitable for in vitro and ex vivo workflows requiring precise dosing and rapid dissolution. For researchers requiring a reliable, selective muscarinic M2 receptor antagonist, (S)-(+)-Dimethindene maleate offers a standardized starting point for experimental design where off-target muscarinic or histaminergic activity must be minimized.

For a detailed exploration of its advanced pharmacological applications, including receptor signaling pathway research and scalable extracellular vesicle biomanufacturing, see this article. For applied protocols and troubleshooting guidance in cardiovascular and respiratory models, refer to this practical guide.

Protocol Parameters

• Solubility preparation (aqueous buffer): 20.45 mg/mL or higher | Suitable for in vitro/ex vivo studies requiring precise dosing | Ensures rapid dissolution and reproducible stock solutions | Value from product dossier
• Recommended storage (solid form): Desiccated, room temperature | Long-term storage prior to use | Prevents hydrolysis and degradation, maintaining compound integrity | Value from product dossier
• Stock solution handling: Prepare fresh; do not store solutions long-term | For all cell-based and tissue assays | Compound stability in solution is limited; use immediately to avoid degradation | Value from product dossier
• Concentration range (workflow recommendation): 0.1–10 μM (typical for receptor antagonism assays) | Use in concentration-response studies for receptor selectivity profiling | Allows titration to determine minimal effective concentration while minimizing off-target effects | Workflow recommendation
• Purity assurance: ≥98.00% | All quantitative and mechanistic studies | Reduces confounding by impurities in pharmacological readouts | Value from product dossier

Workflow Setup and QC Checklist

• Reconstitution: Dissolve the required amount of solid (S)-(+)-Dimethindene maleate in sterile water or buffer to a maximum of 20.45 mg/mL. Vortex briefly and inspect for complete dissolution before use. If insolubility persists, sonication in a water bath (≤5 min) is acceptable. Avoid using organic solvents unless experimentally justified.
• Aliquoting: Prepare single-use aliquots to avoid multiple freeze-thaw cycles. Discard any remaining solution after use; do not freeze or refrigerate diluted solutions for future experiments.
• Assay control: Include vehicle controls to distinguish compound-specific effects from buffer or solvent background. For receptor selectivity profiling, include a known non-selective muscarinic antagonist (e.g., atropine) as a positive control.
• QC on arrival: Record batch number, appearance (solid, color), and verify purity documentation received from APExBIO. Store the product desiccated, at ambient temperature, away from light.
• Documentation: Maintain detailed records of reconstitution, dilution series, and experimental conditions for reproducibility.

Common Failure Modes and Fixes

• Incomplete dissolution: If the compound does not fully dissolve at intended concentrations, confirm the water quality and buffer pH. Increase agitation time or use gentle sonication. Excessive foaming or precipitation suggests the need to reduce concentration or filter the solution with a low protein-binding filter.
• Loss of activity over time: Activity loss often results from prolonged storage of solutions. Always prepare fresh working solutions and use immediately. Discard unused solutions after each session.
• Unexpected off-target effects: Verify that experimental concentrations remain within the selective range for M2 antagonism. Cross-reference controls to identify potential H1 histaminergic involvement, especially in mixed-tissue models.
• Batch-to-batch variability: Confirm batch purity and appearance on arrival. If unexpected results arise, compare with previous lot QC sheets and contact the supplier if inconsistencies persist.

Scope and Limitations

• Scope: (S)-(+)-Dimethindene maleate is optimized for in vitro and ex vivo research targeting M2 muscarinic receptor antagonism, particularly in studies of autonomic regulation, cardiovascular physiology, and respiratory system function. Its high selectivity supports robust pharmacological tool use where minimal off-target muscarinic or histaminergic activity is required.
• Limitations: The compound is not suitable for diagnostic, therapeutic, or in vivo applications unless specifically validated. Its use in studies that require broad muscarinic antagonism (M1–M4) or long-term solution storage is not recommended. Storage and handling must follow the product-specific requirements to ensure experimental reproducibility and compound integrity.

Conclusion

(S)-(+)-Dimethindene maleate (SKU B6734) is a validated, selective M2 muscarinic receptor antagonist and H1 histamine receptor blocker, enabling precise modulation in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. For optimal results, adhere strictly to dissolution, storage, and handling guidelines as detailed above. For further details and to source standardized material, refer to (S)-(+)-Dimethindene maleate at APExBIO.